|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 80, 809-813, Copyright © 1981 by American College of Chest Physicians
ARTICLES |
PE Morrow
Designing a therapeutic aerosol on the basis of its physical properties is a very important objective, but experience has also clearly demonstrated the value of controlling the breathing and drug administration patterns. Presently, the state of aerosol technology is well advanced of its use in medicine. The employment of more sophisticated aerosolization methods can undoubtedly be advocated on both intuitive and scientific grounds, but whether the benefit will justify their cost and complexities is far less evident. This report attempts to set the issue in perspective by reviewing the important properties of commonly-prepared heterodisperse aerosols with monodisperse aerosols of the research laboratory in the context of bronchial deposition and retention.
This article has been cited by other articles:
![]() |
O. S. Usmani, M. F. Biddiscombe, and P. J. Barnes Regional Lung Deposition and Bronchodilator Response as a Function of {beta}2-Agonist Particle Size Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1497 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Usmani, M. F. Biddiscombe, S. R. Underwood, and P. J. Barnes Characterization of the Generation of Radiolabeled Monodisperse Albuterol Particles Using the Spinning-Top Aerosol Generator J. Nucl. Med., January 1, 2004; 45(1): 69 - 73. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |